查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2030330

注射器市場 - 全球產業規模、佔有率、趨勢、機會、預測：按材料、最終用途、地區和競爭格局分類，2021-2031年

Syringes Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Material (Plastic, Glass), By End Use (Hospitals & Clinics, Blood Collection Centers, Ambulatory Care Centers, Others), By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 192 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球注射器市場預計將從 2025 年的 156.7 億美元成長到 2031 年的 223.5 億美元，複合年成長率為 6.1%。

用於採集或輸注體液的標準注射器通常由刻度管、緊密配合的活塞以及可拆卸針頭組成。推動該產業擴張的關鍵因素包括：需要定期注射治療的慢性病盛行率不斷上升、全球人口老化對先進醫療服務的需求日益成長，以及全球免疫接種工作的範圍不斷擴大。這些核心因素共同凸顯了全球對基本醫療注射設備的持續需求。

市場概覽
預測期 2027-2031
市場規模：2025年 156.7億美元
市場規模：2031年 223.5億美元
複合年成長率：2026-2031年 6.1%
成長最快的細分市場 塑膠
最大的市場 北美洲

聯合國兒童基金會2024年供應年度報告反映了這一巨大需求，報告指出，該組織在全球分發了8.8619億支注射器。然而，由於原料持續短缺以及地緣政治緊張局勢擾亂供應鏈並推高製造成本，該行業面臨巨大的成長障礙。不斷上漲的生產成本可能會對這些產品的可負擔性和可及性產生負面影響，尤其是在價格敏感型市場。

市場促進因素

感染疾病和慢性病的發病率不斷上升，在全球注射器產業的形成過程中扮演重要角色。這些健康問題通常需要定期注射治療、診斷程序和持續護理。自體免疫疾病、糖尿病和多種感染疾病等疾病的治療和藥物注射以及臨床檢體採集都高度依賴注射器。例如，根據國際糖尿病聯盟（IDF）發布的《2025年糖尿病地圖集》，到2024年，全球約有5.89億成年人患有糖尿病，其中大多數人需要每日注射胰島素。這種對注射藥物的持續需求是全球注射器使用量成長的主要驅動力。

同時，全球免疫和疫苗宣傳活動的擴展是注射器產業的另一個關鍵促進因素。旨在透過廣泛的免疫接種來控制感染疾病的衛生政策依賴於注射器的持續供應，以進行大規模疫苗接種。這些工作包括常規兒童疫苗、年度流感疫苗以及應對新出現的流行病的策略。聯合國兒童基金會和世界衛生組織於2025年7月15日發布的數據顯示，這些衛生宣傳活動的規模十分龐大，2024年全球約有1.09億嬰幼兒完成了白喉、破傷風和百日咳（DTP）疫苗三劑的接種。此外，領先的醫療技術公司BD（貝克頓·迪金森公司）宣布，截至2024年12月31日的2025會計年度第一季銷售額約為52億美元，凸顯了該公司在該領域的強勁發展勢頭。

市場挑戰

持續的原料短缺和地緣政治問題共同構成國際注射器產業面臨的重大障礙，導致嚴重的供應鏈瓶頸，並推高了製造成本。這些壓力源自於各種國際事件和貿易政策的波動，它們直接影響注射器製造所需關鍵材料的成本和供應。正如醫療績效改進公司 Vizient 在 2025 年 7 月發布的《支出管理展望》中所指出的，包括注射器在內的外科耗材成本預計將在 2026 年成長 3.28%，主要原因是原料價格飆升、製造工資上漲以及運輸成本波動。

不斷上漲的製造成本直接阻礙了產業擴張，降低了產品的可負擔性和可近性，尤其是在預算緊張的醫療網路中。正如美國醫療器材促進協會（AdvaMed）2025年第四季報告所強調的，地緣政治緊張局勢造成了不確定性和關稅風險，可能進一步破壞醫療技術供應鏈的穩定性，並加劇關鍵材料採購的困難。面對不斷上漲的生產成本，製造商可能被迫提高零售價格。這可能會限制低收入地區獲得必要的注射醫療器械，並加重醫療機構的財務負擔。此外，這些物流中斷可能導致運輸延誤和區域性產品短缺，從而直接阻礙全球注射器的穩定供應。

市場趨勢

全球注射器產業正受到預填充式注射器簡化了給藥流程，提高了患者的整體安全性。這一趨勢的驅動力源於對精準便捷給藥方式的需求不斷成長，尤其是在涉及複雜生物製藥的治療以及居家照護環境下的自我給藥療法方面。預填充注射器降低了配藥錯誤的發生機率，減少了污染風險，並提高了醫護人員和病患的便利性。為了體現這一轉變，BD（貝克頓·迪金森公司）於2026年1月13日宣布投資1.1億美元，擴大其在美國的預填充式注射器生產規模，旨在加速GLP-1和生物製藥的給藥，同時支持製藥業重返美國。這項投資計畫凸顯了該行業致力於滿足對這些先進給藥工具日益成長的需求的決心。

同時，安全型注射器的日益普及是另一個重要進展。這主要旨在保護醫護人員免受意外針刺傷，並防止血液傳播疾病的擴散。更嚴格的監管和對職場安全的日益重視，推動了對配備針頭保護罩和可伸縮裝置等防護功能的注射器的持續需求。這些防護功能對於疫苗接種中心、診所和醫院至關重要，並能夠降低意外銳器傷的風險。 2023 年 EXPO-STOP 報告等數據也支持改善職場安全的努力。該報告基於 34 個州 369 家醫療機構的統計數據，顯示每 100 名全職員工中銳器傷的發生率為 2 人。這些數據凸顯了醫療機構持續迫切需要使用更安全的注射裝置，以維持安全的臨床環境。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球注射器市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按材質（塑膠、玻璃）
    • 依用途（醫院/診所、採血中心、門診部、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美注射器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲注射器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區注射器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲注射器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美注射器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球注射器市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Becton Dickinson and Company
  • Terumo Corporation
  • Medtronic plc
  • B. Braun Medical Inc.
  • Nipro Corporation
  • Hindustan Syringes & Medical Devices Ltd.
  • Gerresheimer AG
  • SCHOTT AG
  • CODAN Medizinische Gerate GmbH
  • Baxter Healthcare Corporation

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 7301

The Global market for syringes is anticipated to expand from USD 15.67 billion in 2025 to USD 22.35 billion by 2031, reflecting a compound annual growth rate (CAGR) of 6.1%. Designed to either extract or administer bodily fluids, a standard syringe generally consists of a graded tube, a tightly fitted piston, and frequently a removable needle. The primary catalysts for this industry's expansion include the growing incidence of chronic illnesses that demand regular injectable therapies, an aging global population in need of advanced medical attention, and the broadening scope of worldwide vaccination initiatives. Together, these core elements highlight the ongoing global requirement for fundamental medical injection tools.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 15.67 Billion
Market Size 2031USD 22.35 Billion
CAGR 2026-20316.1%
Fastest Growing SegmentPlastic
Largest MarketNorth America

Reflecting this substantial need, the 2024 UNICEF Supply Annual Report noted that the agency distributed 886.19 million syringes across the globe. Nevertheless, the industry faces notable growth barriers due to ongoing shortages of raw materials and geopolitical tensions that trigger supply chain interruptions, subsequently driving up manufacturing expenses. These higher production costs can negatively affect the affordability and accessibility of these products, especially within markets that are highly responsive to price changes.

Market Driver

The escalating incidence of infectious and chronic illnesses plays a major role in shaping the worldwide syringes industry, given that these health issues frequently require regular injectable therapies, diagnostic procedures, and continuous care. Medical conditions like autoimmune diseases, diabetes, and multiple infectious ailments depend extensively on syringes to deliver medications and draw clinical samples. To illustrate, the 2025 International Diabetes Federation (IDF) Diabetes Atlas reported that roughly 589 million adults worldwide had diabetes in 2024, a large portion of whom need everyday insulin doses. Such relentless need for injectable medications establishes a core catalyst for the global use of syringes.

At the same time, the expansion of global vaccination and immunization campaigns serves as another vital element driving the syringe industry forward. Health initiatives designed to curb infectious diseases via broad vaccination drives depend on an uninterrupted flow of syringes to conduct large-scale inoculations. These efforts include standard childhood shots, annual influenza vaccines, and strategies addressing new pandemics. Data published by UNICEF and the World Health Organization (WHO) on July 15, 2025, indicated that around 109 million babies globally received all three required doses of the diphtheria, tetanus, and pertussis (DTP) vaccine in 2024, highlighting the massive extent of these health campaigns. Additionally, BD (Becton, Dickinson and Company), a prominent medical technology firm, announced roughly $5.2 billion in revenue for its initial fiscal quarter of 2025, which concluded on December 31, 2024, emphasizing the significant financial momentum in this field.

Market Challenge

Ongoing shortages of raw materials combined with geopolitical issues pose a major obstacle for the international syringes industry, causing severe supply chain bottlenecks and driving up manufacturing expenses. These strains originate from diverse international incidents and shifting trade policies that immediately affect the cost and accessibility of crucial materials needed to produce syringes. As noted in the July 2025 Spend Management Outlook by healthcare performance improvement firm Vizient, the cost of surgical supplies, which includes syringes, was forecast to increase by 3.28% in 2026, predominantly fueled by surging raw material rates, higher manufacturing wages, and volatile shipping costs.

These heightened manufacturing costs directly obstruct industry expansion by reducing the affordability and accessibility of products, especially in healthcare networks with strict budgetary limits. As emphasized in AdvaMed's fourth-quarter 2025 report, geopolitical friction creates unpredictability and the risk of tariffs that could additionally unsettle the medical technology supply chain, compounding the difficulty of sourcing vital materials. Producers dealing with increased production costs might be forced to elevate retail prices, which could restrict access to necessary medical injection tools in lower-income areas or add to the financial strain on medical institutions. Furthermore, these logistical interruptions risk causing shipment delays and localized product deficits, directly hindering the steady global supply of syringes.

Market Trends

The international syringes industry is notably influenced by an escalating inclination toward prefilled syringes, which simplify the process of administering medication and improve overall patient security. This movement is fueled by a rising demand for precise and hassle-free drug delivery methods, especially concerning intricate biologic treatments and self-administered therapies utilized in home-based care environments. Prefilled variants lower the chances of mixing mistakes, cut down on contamination hazards, and provide enhanced convenience for medical staff and patients alike. Illustrating this shift, BD (Becton, Dickinson and Company) declared a $110 million financial commitment on January 13, 2026, to scale up its American manufacturing of prefillable syringes, aiming directly at expediting GLP-1 and biologic medication delivery while backing the domestic reshoring of pharmaceuticals. This calculated expenditure underscores the sector's dedication to fulfilling the surging requirement for such sophisticated administration tools.

At the same time, the growing implementation of safety-engineered syringes marks an additional vital development, primarily focused on safeguarding medical personnel against accidental needlesticks and halting the spread of bloodborne diseases. Stricter regulatory rules and an amplified focus on workplace protection are continuously propelling the need for syringes integrated with protective additions like needle shields or retractable mechanisms. Such protective features are essential across vaccination centers, medical clinics, and hospitals to lessen the dangers tied to unintended sharps incidents. The commitment to improved workplace security is reinforced by documents such as the 2023 EXPO-S.T.O.P. report, which revealed a sharps injury rate of 2.0 per 100 full-time equivalent employees, utilizing statistics from 369 medical centers spanning 34 states. These figures highlight the persistent necessity for medical organizations to utilize safer injection equipment to maintain a secure clinical setting.

Key Market Players

  • Becton Dickinson and Company
  • Terumo Corporation
  • Medtronic plc
  • B. Braun Medical Inc.
  • Nipro Corporation
  • Hindustan Syringes & Medical Devices Ltd.
  • Gerresheimer AG
  • SCHOTT AG
  • CODAN Medizinische Gerate GmbH
  • Baxter Healthcare Corporation

Report Scope

In this report, the Global Syringes Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Syringes Market , By Material

  • Plastic
  • Glass

Syringes Market , By End Use

  • Hospitals & Clinics
  • Blood Collection Centers
  • Ambulatory Care Centers
  • Others

Syringes Market , By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Syringes Market .

Available Customizations:

Global Syringes Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Syringes Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Material (Plastic, Glass)
    • 5.2.2. By End Use (Hospitals & Clinics, Blood Collection Centers, Ambulatory Care Centers, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Syringes Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Material
    • 6.2.2. By End Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Syringes Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Material
        • 6.3.1.2.2. By End Use
    • 6.3.2. Canada Syringes Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Material
        • 6.3.2.2.2. By End Use
    • 6.3.3. Mexico Syringes Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Material
        • 6.3.3.2.2. By End Use

7. Europe Syringes Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Material
    • 7.2.2. By End Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Syringes Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Material
        • 7.3.1.2.2. By End Use
    • 7.3.2. France Syringes Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Material
        • 7.3.2.2.2. By End Use
    • 7.3.3. United Kingdom Syringes Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Material
        • 7.3.3.2.2. By End Use
    • 7.3.4. Italy Syringes Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Material
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain Syringes Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Material
        • 7.3.5.2.2. By End Use

8. Asia Pacific Syringes Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Material
    • 8.2.2. By End Use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Syringes Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Material
        • 8.3.1.2.2. By End Use
    • 8.3.2. India Syringes Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Material
        • 8.3.2.2.2. By End Use
    • 8.3.3. Japan Syringes Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Material
        • 8.3.3.2.2. By End Use
    • 8.3.4. South Korea Syringes Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Material
        • 8.3.4.2.2. By End Use
    • 8.3.5. Australia Syringes Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Material
        • 8.3.5.2.2. By End Use

9. Middle East & Africa Syringes Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Material
    • 9.2.2. By End Use
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Syringes Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Material
        • 9.3.1.2.2. By End Use
    • 9.3.2. UAE Syringes Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Material
        • 9.3.2.2.2. By End Use
    • 9.3.3. South Africa Syringes Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Material
        • 9.3.3.2.2. By End Use

10. South America Syringes Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Material
    • 10.2.2. By End Use
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Syringes Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Material
        • 10.3.1.2.2. By End Use
    • 10.3.2. Colombia Syringes Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Material
        • 10.3.2.2.2. By End Use
    • 10.3.3. Argentina Syringes Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Material
        • 10.3.3.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Syringes Market : SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Becton Dickinson and Company
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Terumo Corporation
  • 15.3. Medtronic plc
  • 15.4. B. Braun Medical Inc.
  • 15.5. Nipro Corporation
  • 15.6. Hindustan Syringes & Medical Devices Ltd.
  • 15.7. Gerresheimer AG
  • 15.8. SCHOTT AG
  • 15.9. CODAN Medizinische Gerate GmbH
  • 15.10. Baxter Healthcare Corporation

16. Strategic Recommendations

17. About Us & Disclaimer